Inventor · disambiguated record
Yaochang Xu
Also filed as: XU YAOCHANG
11 granted patents·12 pending applications·2 citations·filing 2014–2023
78Inventor score
Top patents by PatentIndex Score
23 records- 0177US10968220B2FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2017·Granted Apr 6, 2021·1 cites·5 claims
- 0265US11459339B2Biaryl derivative, preparation method thereof and pharmaceutical application thereofABBISKO THERAPEUTICS CO LTD·Filed 2019·Granted Oct 4, 2022·1 cites·13 claims
- 0363US2025382296A1Nitrogen-containing fused three ring prmt5 inhibitor, and preparation method therefor and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0462US2025320202A1Prmt5 inhibitor, preparation method therefor, and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0560US11555036B2FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2020·Granted Jan 17, 2023·0 cites·3 claims
- 0660US2024408088A1Pyrazole derivative, and preparation method therefor and use thereof in medicineABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0758US2025179023A1Holosymmetric biphenyl derivative, and preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0855US2024360102A1Pyrimidine-4,6-diamine derivative, a preparation method therefor, and a pharmaceutical application thereofABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0954US2024327402A1Pyrimidine or pyridine derivative, preparation method therefor, and application thereof in pharmacyABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1054US2024109885A12,3-dihydro-1h-pyrrolo[3,2-b]pyridine derivative, preparation method therefor, and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1153US2024101573A1Macrocyclic k-ras g12c inhibitor, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1252US2023303575A1Fgfr and mutation inhibitor thereof, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1350US2022009894A11,2,3,4-tetrahydroquinoxaline derivative, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
- 1449US12473282B2Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Granted Nov 18, 2025·0 cites·15 claims
- 1549US2023271936A1Efgr inhibitor, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1645US12157755B2CD73 inhibitor, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2020·Granted Dec 3, 2024·0 cites·8 claims
- 1745US2022380342A1Biphenyl derivatives for blocking pd-1/pd-l1 interaction, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 1844US12351576B2FGFR inhibitor, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2019·Granted Jul 8, 2025·0 cites·6 claims
- 1941US11312701B2Formylpyridine derivative having FGFR4 inhibitory activity, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Apr 26, 2022·0 cites·6 claims
- 2041US11130762B2Azaaryl derivative, preparation method therefor, and application thereof for use in pharmacyABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Sep 28, 2021·0 cites·14 claims
- 2139US11180495B2Nitrogen heteroaryl derivative having CSF1R inhibitory activity, and preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Nov 23, 2021·0 cites·9 claims
- 2235US11149021B2N-(azaaryl)cyclolactam-1-carboxamide derivative, preparation method therefor, and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Oct 19, 2021·0 cites·21 claims
- 2335US10011627B2C-aryl glucoside derivative, preparation methods thereof, and medical applications thereofYOUNGENE THERAPEUTICS CO LTD·Filed 2014·Granted Jul 3, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Yaochang Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →